Editor’s Choice: Lunchbox Trial Listen to Gynecologic Oncology

Editor’s Choice Paper: 
Lunchbox trial: A randomized phase III trial of cisplatin and irradiation followed by carboplatin and paclitaxel versus sandwich therapy of carboplatin and paclitaxel followed by irradiation then carboplatin and paclitaxel for advanced endometrial carcinoma

Editorial:
What's in your “lunchbox”? Sandwich versus sequential chemotherapy and irradiation for advanced endometrial cancer

Hosted by:
Ursula Matulonis, MD, Associate Editor of Gynecologic Oncology



Featuring:
Joyce Barlin, MD, Women’s Cancer Care Associates & Albany Medical College
Gretchen Glaser, MD, Mayo Clinic 
John Weroha, MD, Mayo Clinic